Implications of plastic-derived endocrine disruptors on human health

dc.contributor.authorOjo, Adebola Busola
dc.contributor.authorAgbeye, Oluwatobi Deborah
dc.contributor.authorOgwa, Theophilus Oghenenyoreme
dc.contributor.authorAdedoyin, Damilola
dc.contributor.authorRotimi, Damilare Emmanuel
dc.contributor.authorOjo, Oluwafemi Adeleke
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.converis.publication-id498723987
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/498723987
dc.date.accessioned2026-01-21T14:59:43Z
dc.date.available2026-01-21T14:59:43Z
dc.description.abstractEndocrine-disrupting chemicals (EDCs), such as bisphenol A (BPA), bisphenol S (BPS), phthalates, and micro- and nanoplastics, present substantial environmental and health hazards because of their potential to disrupt hormonal systems. Micro- and nanoplastics can release EDCs that disrupt reproductive and developmental processes, potentially affecting future generations. BPA, a common plasticizer and resin component, mimics estrogen and disrupts thyroid hormone metabolism, contributing to obesity, diabetes, and cardiovascular issues. BPS, a BPA substitute, exhibits similar endocrine-disrupting properties and persists longer in the environment. Phthalates, which are widely used as plasticizers, are associated with reproductive issues, metabolic conditions, and developmental issues in children. Combined exposure to multiple EDCs can amplify health risks, underscoring the need for further research on the synergistic impacts of these chemicals. This review underscores the urgent need for effective regulatory measures and further investigations into the health impacts of EDCs to mitigate their harmful impacts on the health of humans and the environment.
dc.embargo.lift2026-07-17
dc.identifier.eissn1537-6524
dc.identifier.jour-issn1537-6516
dc.identifier.olddbid213968
dc.identifier.oldhandle10024/196986
dc.identifier.urihttps://www.utupub.fi/handle/11111/56190
dc.identifier.urlhttps://doi.org/10.1080/15376516.2025.2510525
dc.identifier.urnURN:NBN:fi-fe202601217296
dc.language.isoen
dc.okm.affiliatedauthorOjo, Oluwafemi
dc.okm.discipline3111 Biomedicineen_GB
dc.okm.discipline3111 Biolääketieteetfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA2 Scientific Article
dc.publisherTAYLOR & FRANCIS LTD
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.publisher.placeABINGDON
dc.relation.doi10.1080/15376516.2025.2510525
dc.relation.ispartofjournalToxicology Mechanisms and Methods
dc.source.identifierhttps://www.utupub.fi/handle/10024/196986
dc.titleImplications of plastic-derived endocrine disruptors on human health
dc.year.issued2025

Tiedostot